Could tailored brain stimulation quiet Parkinson's tremors more effectively?

NCT ID NCT04799470

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This pilot study is testing whether personalized deep brain stimulation (DBS) patterns can better control Parkinson's motor symptoms while causing fewer side effects than standard settings. Researchers will enroll 10 people already implanted with the Medtronic Percept PC DBS device and compare their usual stimulation with new, patient-tailored patterns. The goal is to see if targeting excessive brain synchrony more precisely leads to smoother movement and less discomfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
novel deep brain stimulation patterns delivered via the Medtronic Percept PC device
What this could lead to
If successful, this could point toward more effective and personalized DBS therapy for Parkinson's disease with fewer side effects.
What could go wrong
This is a very small, early feasibility pilot with only 10 participants, so results may not apply broadly. The novel patterns may not work better than standard stimulation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Unversity of Nebraska Medical Center

    RECRUITING

    Omaha, Nebraska, 68118, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.